Back to discover
Disease

Klinefelter Syndrome

Late-stage therapeutic developmentEmerging research
1
Publications
9
Clinical trials
2023
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism.

Research2023-11-04International journal of molecular sciences

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

6 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
9
All trials
2
Active
5
Late-stage
6
Completed
Recently completed

TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY

Phase 4 · Completed · University of Colorado, Denver

Androgen Effect on Motor/Cognitive Outcome in Klinefelter Syndrome

Phase 2 · Completed · Thomas Jefferson University

Androgen Treatment in Leydig Cell Proliferation

Phase 2/3 · Completed · University of Roma La Sapienza

Management of Azoospermic Patients With Kleinfelter Syndrome Patients With Mesenchymal Stem Cell Injection

N/A · Completed · Man Clinic for Andrology, Male Infertility and Sexual Dysfunction

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism.

International journal of molecular sciences · 2023 · 18 cites
Recent publications

Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism.

International journal of molecular sciences · 2023 · 18 cites
Major themes3
  • Hypogonadism1
  • Klinefelter Syndrome1
  • Puberty, Delayed1
Leading journals1
  • International journal of molecular sciences1
Leading researchers5
  • Fanis P1
  • Neocleous V1
  • Papapetrou I1
  • Phylactou LA1
  • Skordis N1
Affiliations (unnormalised)3
  • Paedi Center for Specialized Paediatrics1
  • School of Medicine1
  • The Cyprus Institute of Neurology and Genetics1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A form of male HYPOGONADISM, characterized by the presence of an extra X CHROMOSOME, small TESTES, seminiferous tubule dysgenesis, elevated levels of GONADOTROPINS, low serum TESTOSTERONE, underdeveloped secondary sex characteristics, and male infertility (INFERTILITY, MALE). Patients tend to have long legs and a slim, tall stature. GYNECOMASTIA is present in many of the patients. The classic form has the karyotype 47,XXY. Several karyotype variants include 48,XXYY; 48,XXXY; 49,XXXXY, and mosaic patterns ( 46,XY/47,XXY; 47,XXY/48,XXXY, etc.).

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.